Timothy A. Masterson, Md

Total Page:16

File Type:pdf, Size:1020Kb

Timothy A. Masterson, Md

TIMOTHY A. MASTERSON, MD

Department of Urology Indiana University Medical Center 535 N. Barnhill Dr., Suite 420 Indianapolis, IN 46202 317-278-7560

EDUCATION

M.D. Indiana University School of Medicine Indianapolis, Indiana August 1997- May 2001

B.S. Indiana University Bloomington, Indiana August 1993- May 1997 Major- Biology, graduated cum laude

PROFESSIONAL TRAINING

Fellowship Memorial Sloan-Kettering Cancer Center Department of Surgery, Division of Urology July 2006- December 2008

Residency University of Utah Health Science Center Department of Surgery, Division of Urology June 2002- June 2006

Internship University of Utah Health Science Center Department of Surgery June 2001- June 2002

FACULTY APPOINTMENTS

January 2009- Assistant Professor present Department of Urology Indiana University School of Medicine Indianapolis, Indiana

Chief of Urology Service Wishard Memorial Hospital Indianapolis, Indiana

HONORS & AWARDS

Fellowship Administrative Chief Clinical Fellow Memorial Sloan-Kettering Cancer Center Urology Service January-July 2007 Who’s Who in Medicine and Healthcare, 2006-2007

Residency AUA/Threshold Gerald P. Murphy scholar, 2006 AUA/Threshold Gerald P. Murphy scholar, 2005 Willet Whitmore Memorial Scholarship Memorial Sloan-Kettering Cancer Center September 2004 Earl F. Nation Resident Scholarship Recipient, 2004

Medical School AMA-MSS Treasurer for the Indiana delegation, 1999-2001 AMA-MSS Representative for the Indiana delegation Terre Haute Center, 1997-1999 Student Council Representative for the Terre Haute Center for Medical Education, 1997-1999 Dr. Arnold Kunkler Scholarship for Academic Excellence, 1998

Undergraduate Phi Beta Kappa National Honor Society School Golden Key National Honor Society Dean’s Honor Role, last seven collegiate semesters Sigma Alpha Epsilon Foundation Dr. Charles Preuss Medical Scholarship, 1997

BOARD CERTIFICATION AND LICENSURE

February 2010 The Certifying (Part II) Examination of the American Board of Urology August 2006 The Qualifying (Part 1) Examination of the American Board of Urology

July 18th, 2008- State of Indiana Physician License #01065620A June 30th, 2011 State of Indiana Controlled Substance License #01065620B

February 2006- State of New York Medicine and Surgery License #238907 present December 2002- Drug Enforcement Agency Registration #BM8099613 present November 2002 State of Utah Physician and Surgeon License #5181738-1205 November 2002 State of Utah Physician and Surgeon Controlled Substance #5181738-8905 May 2002 USMLE III September 2000 USMLE II June 1999 USMLE I

PROFESSIONAL MEMBERSHIPS & SOCIETIES

2006-present Society of Urologic Oncologist 2003-present American Association of Clinical Urologist, Inc. 2002-present American Urologic Association 2002-2006 Utah Urologic Society 2001-2006 Utah Medical Association 1997-2001 American Medical Association 1997-2001 Indiana State Medical Association

ABSTRACTS, PUBLICATIONS, AND ONGOING RESEARCH

ABSTRACTS:

Masterson TA, Dill A, Koch MO, Ratliff T, Cheng L, Cooks G. Molecular Pathology from lipid profiles of human transitional cell carcinoma and adenocarcinoma of the prostate by desorption electrospray ionization (DESI) imaging mass spectrometry. Accepted for publication in the American Society of Clinical Oncology Annual Meeting proceedings, Chicago IL 2010.

Masterson TA, Ratliff T. DESI and cholesterol sulfate in urologic cancers: clinical and translational applications. IU-Purdue annual research retreat, Carmel, IN February 2010.

Masterson TA, Wedmid A, Sandhu JS, Eastham JA. Outcomes after radical prostatectomy in men receiving prior pelvic radiation for non-prostate malignancies. Society of Urologic Oncology Winter Meeting, Bethesda, MD 2008. Masterson TA, Carver BS, Motzer RJ, Bosl GJ, Sheinfeld J. Clinical outcomes in clinical stage III NSGCT patients who achieve a complete radiographic response to chemotherapy at the site of extra-retroperitoneal disease. SUO - Young Urologic Oncologists Podium Abstract Presentations, Society of Urologic Oncology Winter Meeting, Bethesda, MD 2008.

Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modification in technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. Society of Urologic Oncology Winter Meeting, Bethesda, MD 2007.

Masterson TA, Dechet CB. Effect of neurovascular bundle preservation during radical retropubic prostatectomy on urinary control: a prospective analysis. AUA Western Section, Vancouver 2005.

Masterson TA, Dechet CB. Management of renal tumor involving isthmus of horseshoe kidney: a case report. AUA Western Section, San Diego, CA 2004.

Masterson TA, Chan K, Lawson EA, Dechet CB. Health-related and disease specific quality of life scores 12 months after radical prostatectomy: a prospective analysis. AUA Western Section, San Diego, CA 2004.

Masterson TA, Pettus JA, Middleton RG, Stephenson RA. Impact of isolated seminal vesicle invasion in radical prostatectomy specimens. AUA Western Section, Lake Las Vegas, NV 2003.

Pettus JA, Masterson TA, Middleton RG, Stephenson RA. Implication of isolated apical margins in radical prostatectomy specimens. AUA Western Section, Lake Las Vegas, NV 2003.

MANUSCRIPTS AND PUBLICATIONS:

Masterson TA, Dill AL, Eberlin LS, Mattarozzi M, Cheng L, Beck SDW, Bianchi F, Cooks RG. Dinstinctive glycerophospholipid profiles of human seminoma and adjacent normal tissues by desorptive electrospray ionization imaging mass spectrometry. Submitted to Journal of Urology, August 2010.

Dill AL, Eberlin LS, Costa AB, Zheng C, Ifa DR, Cheng L, Masterson TA, Koch MO, Vitek O, Cooks RG. Molecular pathology and classification based on lipid profiles of human carcinoma of the urinary bladder using imaging mass spectrometry. Submitted to Angewandte Chemie, May 2010. Masterson TA, Cheng L, Koch MO. Pathologic characterization of unifocal prostate cancers in whole-mount radical prostatectomy specimens. Accepted for publication to BJU-International, May 2010.

Eberlin LS, Dill AL, Costa AB, Ifa DR, Cheng L, Masterson T, Koch M, Ratliff TL, Cooks RG. Cholerstol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Analytical Chemistry, 2010 May;82(9):3430- 4. Epub 2010 April 7.

Vickers AJ, Cronin AM, Masterson TA, Eastham JA. How do you tell whether a change in surgical technique leads to a change in outcome? Journal of Urology, 2010 April;183(4):1510-4. Epub 2010 February 20. Risk MC, Masterson TA. Intratubular germ cell neoplasms of testis and bilateral testicular tumors: clinical significance and management options. Invited review for a symposium on “Management of Germ Cell Tumors of the Testis”. Indian Journal of Urology, 2010 Jan;26(1):64-71. Gross J, Masterson TA, Cheng L, Johnstone PAS. pT0 prostate cancer after radical prostatectomy. Journal of Surgical Oncology, 2010 Jan 29 [Epub ahead of print].

Masterson TA, Beck SDW. Testis Cancer: Clinical Signs and Symptoms. In Comprehensive Textbook of Genitourinary Oncology, 4th Edition. Volgelzang, Scardino, Zelefsky, &Linehan, eds. Lippincott Williams & Wilkins. In press 2009 Nov.

Bahler CD, Foster RS, Birhle R, Beck SDW, Gardner TA, Sundaram CP, Masterson TA, Cheng L, Koch MO. Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer. BJU-International, 2009 October 26;105(10):1372-6. Epub 2009 Oct 26.

Pettus JA, Masterson TA, Sokol A, Cronin AM, Savage C, Sandhu JS, Mulhall JP, Scardino PT, Rabbani F. Prostate size is associated with surgical difficulty but not functional outcome at one year after radical prostatectomy. Journal of Urology, 2009 Sept; 182(3):949-55. Epub 2009 July 17.

Masterson TA, Wedmid A, Sandhu JS, Eastham JA. Outcomes after radical prostatectomy in men receiving prior pelvic radiation for non-prostate malignancies. BJU International, 2009 Aug; 104(4):482-5. Epub 2009 February 23.

Abel EJ, Masterson TA, Warner JN, Valentine K, Dechet CB. Nerve sparing prostatectomy and urinary function: a prospective analysis using validated quality of life measures. Urology, 2009 June;73(6):1336-40. Epub 2009 April 9.

Wedmid A, Masterson TA, Maki R, Russo R. A case of high-risk epithelioid hemangioendothelioma. Nature of Clinical Practice-Urology, 2009 April;6(4):223-7. Epub 2008 October 11. Pettus JA, Carver BS, Masterson TA, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology, 2009 February;73(2):328-31. Epub 2008 November 19.

Masterson TA, Eastham JA. Surgical treatment of prostate cancer. In Contemporary Issues in Cancer Imaging: Cancer of the Prostate. Hricak & Scardino, eds. Cambridge University Press, 2008 December.

Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathologic upgrading and upstaging with immediate repeat biopsy in patients eligible for active surveillance. Journal of Urology, 2008 November;180(5):1964-7; discussion 1967- 8. Epub 2008 September 17.

Masterson TA, Touijer AK. The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer. Magnetic Resonance Materials in Physics, Biology and Medicine (MAGMA), 2008 November;21(6):371-7. Epub 2008 August 27.

Masterson TA, Russo P. A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy. Nature Clinical Practice Urology. 2008 June;5(6):345-9. Epub 2008 May 2.

Pettus JA, Masterson TA, Abel EJ, Middleton RG, Stephenson RA. Risk stratification for positive lymph nodes in prostate cancer. Journal of Endourology. 2008 May;22(5):1021-5. Epub 2008 April 7.

Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU International. 2008 May; 101(10):1217- 22. Epub 2008 Feb 15.

Cartwright PC, Masterson TA, Snow BW. Office Urology. In Clinical Pediatric Urology, 5th Edition. Docimo, Canning & Koury, eds. Taylor and Francis Books, 2007 January.

Masterson TA, Bianco FJ Jr, Vickers AJ, DiBlasio CJ, Fearn PA, Rabbani F, Eastham JA, Scardino PT. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. Journal of Urology. 2006 April; 175(4):1320-4; discussion 1324-5.

Masterson TA, Stephenson AJ, Scardino PT, Eastham JA. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005 September; 66(3):623-6. Masterson TA, Middleton RG. AUA Update Series- Iatrogenic rectourethral fistulas: current management. AUA Update Series 2005; volume 24, lesson 8.

Masterson TA, Pettus JA, Middleton RG, Stephenson RA. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pT3b disease by nodal and margin status. Urology. 2005 July; 66(1):152-155.

ONGOING LABORATORY AND CLINICAL RESEARCH:

Germ cell tumors of undescended testes: clinical patterns of care and outcomes. Gullett N, Masterson TA, Johnstone PAS. STATUS: manuscript in preparation.

A Pilot Study of Neoadjuvant Dasatinib Followed by Radical Cystectomy for Transitional Cell Carcinoma of the Bladder; Sponsors are Hoosier Oncology Group and Bristol Myers Squibb; PI is Noah Hahn, MD

Desportive Electrospray Ionization (DESI) for tumor and non-tumor tissue discrimination in urologic cancers. Masterson TA, Koch MO, Cheng L, Ratliff TL, Cooks RG. STATUS: Analyzing tissues.

Predictors of histologic findings in residual masses at the extra-retroperitoneal site after chemotherapy in clincal stage III NSGCT patients. Masterson TA, Carver BS, Shayegan B, Motzer RJ, Bosl GJ, Sheinfeld J. STATUS: Analyzing data.

Clinical outcomes in clincal stage III NSGCT patients who achieve a complete radiographic response to chemotherapy at the site of extra-retroperitoneal disease. Masterson TA, Carver BS, Shayegan B, Motzer RJ, Bosl GJ, Sheinfeld J. STATUS: Manuscript in preparation for the Journal of Clinical Oncology.

Impact of age on the surgical management of testis cancer. INVESTIGATORS: Masterson TA, Carver BS, Abel EJ, Pettus JA, Sheinfeld J. STATUS: Manuscript in preparation for the Journal of Urology.

Impact of residual extra-retroperitoneal masses in patients with advanced non- seminomatous germ cell tumors. INVESTIGATORS: Masterson TA, Carver BS, Shayegan B, Motzer RJ, Bosl GJ, Sheinfeld J. STATUS: Manuscript in preparation for the Journal of Clinical Oncology.

Recommended publications